Objectives: Crohn's disease (CD), ulcerative colitis (UC), intestinal Behçet's disease (BD), intestinal tuberculosis (ITB), and primary intestinal lymphoma (PIL) are major intestinal disorders that frequently present with mucosal ulceration. Accurate differentiation among these conditions is challenging due to overlapping clinical, endoscopic, and imaging characteristics. Accordingly, this study aimed to develop an artificial intelligence (AI)-assisted endoscopic diagnostic system to accurately identify these five diseases.
Methods: This multicenter prospective study used endoscopic images from patients diagnosed with pathologically confirmed CD, UC, BD, ITB, and PIL to develop an AI system that uses convolutional neural networks (CNNs) and transformer architectures. It was validated across multiple centers compared with endoscopist performance, and assessed prospectively. In addition, clinical data were integrated to construct a comprehensive diagnostic model.
Results: Internal validation revealed that the AI system achieved an accuracy of 96.8%, with sensitivities for the five ulcerative diseases ranging from 76.9% to 97.8%. In the multicenter test (Test A + Test B3), diagnostic accuracy reached 83.4%, outperforming endoscopists. Prospective evaluation revealed that AI system demonstrated significantly higher accuracy than senior endoscopists (83.4% versus 59.4%, P < 0.001). Moreover, the optimal comprehensive model, which combined clinical and endoscopic data, achieved an accuracy of 76.3%.
Conclusions: An AI-assisted endoscopic diagnostic system that accurately differentiates CD, UC, BD, ITB, and PIL was developed, which may contribute to improving diagnostic precision for colorectal ulcerative diseases.
目的:克罗恩病(CD)、溃疡性结肠炎(UC)、肠behet病(BD)、肠结核(ITB)和原发性肠淋巴瘤(PIL)是主要的肠道疾病,常伴有粘膜溃疡。由于重叠的临床、内窥镜和影像学特征,对这些疾病的准确区分具有挑战性。因此,本研究旨在开发一种人工智能(AI)辅助的内镜诊断系统,以准确识别这五种疾病。方法:本多中心前瞻性研究使用病理确诊的CD、UC、BD、ITB和PIL患者的内镜图像,开发使用卷积神经网络(cnn)和变压器架构的人工智能系统。与内窥镜医师的表现进行了多中心验证,并进行了前瞻性评估。结合临床资料,构建综合诊断模型。结果:内部验证显示,AI系统的准确率为96.8%,对五种溃疡性疾病的敏感性为76.9%至97.8%。在多中心测试(test A + test B3)中,诊断准确率达到83.4%,优于内镜医师。前瞻性评价显示,AI系统的准确率明显高于资深内窥镜医师(83.4% vs 59.4%), P结论:开发了一种能够准确区分CD、UC、BD、ITB和PIL的AI辅助内镜诊断系统,有助于提高结直肠溃疡性疾病的诊断精度。
{"title":"Development and application of an artificial intelligence-assisted endoscopic system for automatic and accurate diagnosis of colorectal ulcers.","authors":"Zhihang Yu, Xinyuan Liu, Xinkun Yu, Yiping Xin, Shuigeng Zhou, Xiaoyu Li","doi":"10.1007/s00384-025-05029-y","DOIUrl":"10.1007/s00384-025-05029-y","url":null,"abstract":"<p><strong>Objectives: </strong>Crohn's disease (CD), ulcerative colitis (UC), intestinal Behçet's disease (BD), intestinal tuberculosis (ITB), and primary intestinal lymphoma (PIL) are major intestinal disorders that frequently present with mucosal ulceration. Accurate differentiation among these conditions is challenging due to overlapping clinical, endoscopic, and imaging characteristics. Accordingly, this study aimed to develop an artificial intelligence (AI)-assisted endoscopic diagnostic system to accurately identify these five diseases.</p><p><strong>Methods: </strong>This multicenter prospective study used endoscopic images from patients diagnosed with pathologically confirmed CD, UC, BD, ITB, and PIL to develop an AI system that uses convolutional neural networks (CNNs) and transformer architectures. It was validated across multiple centers compared with endoscopist performance, and assessed prospectively. In addition, clinical data were integrated to construct a comprehensive diagnostic model.</p><p><strong>Results: </strong>Internal validation revealed that the AI system achieved an accuracy of 96.8%, with sensitivities for the five ulcerative diseases ranging from 76.9% to 97.8%. In the multicenter test (Test A + Test B3), diagnostic accuracy reached 83.4%, outperforming endoscopists. Prospective evaluation revealed that AI system demonstrated significantly higher accuracy than senior endoscopists (83.4% versus 59.4%, P < 0.001). Moreover, the optimal comprehensive model, which combined clinical and endoscopic data, achieved an accuracy of 76.3%.</p><p><strong>Conclusions: </strong>An AI-assisted endoscopic diagnostic system that accurately differentiates CD, UC, BD, ITB, and PIL was developed, which may contribute to improving diagnostic precision for colorectal ulcerative diseases.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"40 1","pages":"242"},"PeriodicalIF":2.3,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12672593/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145661110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-02DOI: 10.1007/s00384-025-05019-0
Christina G Truelsen, Camilla S Kronborg, Anne Ramlov, Christian A Hvid, Karen-Lise G Spindler
Purpose: Preoperative radiotherapy (pRT) for rectal cancer (RC) reduces local recurrence rates. However, treatment-induced side effects may compromise patient-reported quality of life (QoL). This study aimed to report longitudinal QoL and physician-assessed toxicity in RC patients receiving preoperative intensity modulated radiotherapy (IMRT).
Methods: This prospective cohort study included 123 RC patients treated with short-course (SCRT) or long-course chemoradiotherapy (LCRT). Patient-reported outcomes (PRO) were assessed using the EORTC QLQ-C30 and CR29 questionnaires at pretreatment, end of treatment, preoperatively, and at 1-year follow-up. Physician-reported toxicity was evaluated using Common Terminology Criteria for Adverse Events (CTCAE). Longitudinal changes in PROs were analysed using mixed-effects regression modelling. CTCAE grades were reported as frequencies, and symptom transitions illustrated using Sankey diagrams.
Results: For EORTC C30 items, pRT-induced transient declines were observed for Global Health, physical, role and social functioning, fatigue, and pain, with scores recovering at preoperative assessment, except for persistent worsening for fatigue. At 1-year, Global Health remained stable; emotional functioning improved; fatigue and social functioning showed minor persistent worsening. Bowel and bladder symptoms peaked during pRT and gradually resolved or improved at 1Y. CTCAE grades were predominantly mild; diarrhoea and rectal bleeding improved over time, while urinary dysfunction and fatigue increased modestly. Sankey plots illustrate symptom transitions. Discrepancies were noted between physician- and patient-reported outcomes.
Conclusion: IMRT-based pRT was associated with largely preserved QoL at 1Y. Reported trajectories of PRO and CTCAE scores provide complementary insights to support physician-patient communication, with differences underlining the importance of integrating both perspectives.
{"title":"Longitudinal assessment of quality of life and symptom burden in locally advanced rectal cancer patients receiving IMRT-based preoperative radiotherapy: A prospective cohort study.","authors":"Christina G Truelsen, Camilla S Kronborg, Anne Ramlov, Christian A Hvid, Karen-Lise G Spindler","doi":"10.1007/s00384-025-05019-0","DOIUrl":"10.1007/s00384-025-05019-0","url":null,"abstract":"<p><strong>Purpose: </strong>Preoperative radiotherapy (pRT) for rectal cancer (RC) reduces local recurrence rates. However, treatment-induced side effects may compromise patient-reported quality of life (QoL). This study aimed to report longitudinal QoL and physician-assessed toxicity in RC patients receiving preoperative intensity modulated radiotherapy (IMRT).</p><p><strong>Methods: </strong>This prospective cohort study included 123 RC patients treated with short-course (SCRT) or long-course chemoradiotherapy (LCRT). Patient-reported outcomes (PRO) were assessed using the EORTC QLQ-C30 and CR29 questionnaires at pretreatment, end of treatment, preoperatively, and at 1-year follow-up. Physician-reported toxicity was evaluated using Common Terminology Criteria for Adverse Events (CTCAE). Longitudinal changes in PROs were analysed using mixed-effects regression modelling. CTCAE grades were reported as frequencies, and symptom transitions illustrated using Sankey diagrams.</p><p><strong>Results: </strong>For EORTC C30 items, pRT-induced transient declines were observed for Global Health, physical, role and social functioning, fatigue, and pain, with scores recovering at preoperative assessment, except for persistent worsening for fatigue. At 1-year, Global Health remained stable; emotional functioning improved; fatigue and social functioning showed minor persistent worsening. Bowel and bladder symptoms peaked during pRT and gradually resolved or improved at 1Y. CTCAE grades were predominantly mild; diarrhoea and rectal bleeding improved over time, while urinary dysfunction and fatigue increased modestly. Sankey plots illustrate symptom transitions. Discrepancies were noted between physician- and patient-reported outcomes.</p><p><strong>Conclusion: </strong>IMRT-based pRT was associated with largely preserved QoL at 1Y. Reported trajectories of PRO and CTCAE scores provide complementary insights to support physician-patient communication, with differences underlining the importance of integrating both perspectives.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"40 1","pages":"239"},"PeriodicalIF":2.3,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12672606/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145661161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-20DOI: 10.1007/s00384-025-05021-6
Marie Tønsberg Ib, Olga Teresa Holbek, Anders Tøttrup
The purpose of the present study was to perform a systematic review and meta-analysis of the available literature on the surgical management of Hinchey III diverticulitis comparing laparoscopic lavage with surgical resection.
Methods: A PubMed and EMBASE search using well-defined mesh terms was used. All identified papers were screened for possible inclusion in the study by initial review of abstracts. Only randomized trials were included in the meta-analysis.
Results: The search resulted in 23 studies available for closer investigation. We managed to identify 3 separate randomized trials comparing the outcome after laparoscopic lavage and sigmoid resection for Hinchey III diverticulitis. Early and late results of these trials have been reported in 7 scientific papers constituting the basis of the present systematic review and meta-analysis. For the different endpoints, pooled data from between 292 and 380 patients randomized to either sigmoid resection or laparoscopic lavage was available for analysis. Ninety-day mortality was similar between the groups (OR = 0.69 (0.32-1.49)), but the risk of severe complications and of recurrent diverticulitis was lower among patients randomized to sigmoid resection (OR = 0.61 (0.38-0.98) and OR = 0.15 (0.05-0.44), respectively). The risk of having a stoma after 1 year was higher among patients randomized to resection (OR = 2.97 (1.30-6.81)). No significant differences were identified regarding the need for reoperation. Subsequent analysis of data from two of the randomized trials showed that smoking and use of immunosuppressant medications were associated with a poorer outcome after laparoscopic lavage.
Conclusions: Laparoscopic lavage has certain advantages when compared to resection for Hinchey III diverticulitis, but should be used with caution in smokers and patients taking immunosuppressants. After lavage, recurrent diverticulitis (often uncomplicated) is likely to occur. Resection with primary anastomosis is a good option in stable and fit patients when surgical expertise is available, but for a number of patients, resection with formation of a stoma seems to be the safest option.
{"title":"The surgical management of perforated diverticulitis Hinchey III: a systematic review and meta-analysis.","authors":"Marie Tønsberg Ib, Olga Teresa Holbek, Anders Tøttrup","doi":"10.1007/s00384-025-05021-6","DOIUrl":"10.1007/s00384-025-05021-6","url":null,"abstract":"<p><p>The purpose of the present study was to perform a systematic review and meta-analysis of the available literature on the surgical management of Hinchey III diverticulitis comparing laparoscopic lavage with surgical resection.</p><p><strong>Methods: </strong>A PubMed and EMBASE search using well-defined mesh terms was used. All identified papers were screened for possible inclusion in the study by initial review of abstracts. Only randomized trials were included in the meta-analysis.</p><p><strong>Results: </strong>The search resulted in 23 studies available for closer investigation. We managed to identify 3 separate randomized trials comparing the outcome after laparoscopic lavage and sigmoid resection for Hinchey III diverticulitis. Early and late results of these trials have been reported in 7 scientific papers constituting the basis of the present systematic review and meta-analysis. For the different endpoints, pooled data from between 292 and 380 patients randomized to either sigmoid resection or laparoscopic lavage was available for analysis. Ninety-day mortality was similar between the groups (OR = 0.69 (0.32-1.49)), but the risk of severe complications and of recurrent diverticulitis was lower among patients randomized to sigmoid resection (OR = 0.61 (0.38-0.98) and OR = 0.15 (0.05-0.44), respectively). The risk of having a stoma after 1 year was higher among patients randomized to resection (OR = 2.97 (1.30-6.81)). No significant differences were identified regarding the need for reoperation. Subsequent analysis of data from two of the randomized trials showed that smoking and use of immunosuppressant medications were associated with a poorer outcome after laparoscopic lavage.</p><p><strong>Conclusions: </strong>Laparoscopic lavage has certain advantages when compared to resection for Hinchey III diverticulitis, but should be used with caution in smokers and patients taking immunosuppressants. After lavage, recurrent diverticulitis (often uncomplicated) is likely to occur. Resection with primary anastomosis is a good option in stable and fit patients when surgical expertise is available, but for a number of patients, resection with formation of a stoma seems to be the safest option.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"40 1","pages":"238"},"PeriodicalIF":2.3,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12630160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145556834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-19DOI: 10.1007/s00384-025-05017-2
Riccardo Guanà, Ana Sofia Soto Torselli, Francesco De Leo, Benedetta Marino, Silvia Perin, Giada Morgani, Marco Ettore Allaix, Matilde Piglione, Valentina Di Martino, Enrico Costantino Falco, Fabrizio Gennari
Introduction: Colorectal carcinoma (CC) is a rare disease in the pediatric population, with an annual incidence of 1 in 10 million adolescents, and it accounts for approximately 1% of pediatric solid neoplasms. It is the most common primary gastrointestinal malignancy in children with the vast majority of CCs being adenocarcinoma (CA). Unfortunately, the proportion of poorly differentiated, mucinous type, signet-ring cell containing carcinomas is higher in younger patients than in adults. Moreover, due to the low awareness of the disease, diagnosis is usually delayed until advanced stages, resulting in an extremely poor prognosis. Surgery is the only curative modality for localized CAs, whereas adjuvant chemotherapy is the standard of care for patients with stage III cancer to eradicate micro-metastases.
Patients and methods: In the last 10 years, we treated 3 patients diagnosed with CA: a 14-year-old female, a 15-year-old male, and a 15-year-old female. All patients presented to our Emergency Department with nonspecific symptoms of abdominal pain and vomiting.
Results: All patients were subjected to laparoscopic tumor resection to relief intestinal obstruction. In the male patient, laparoscopy was converted to laparotomy to safely assess the anatomy because of strong peritoneal adhesions. No stomas were created, in order to improve quality of life. Oxaliplatin and 5-fluorouracil-based regimens were among the most commonly used chemotherapy combinations. The 15-year-old female and the 15-year-old male died 1 year after the surgical resection, while the 14-year-old female is still on follow-up.
Conclusions: CAs behave aggressively in children; they not only show a poorer response to chemotherapy, but are also associated with extensive intramural spread and peritoneal carcinomatosis. Lack of awareness and timely intervention remain the main challenges for early diagnosis and improved prognosis of CA.
{"title":"Colorectal adenocarcinoma in children and adolescents: the management of advanced disease.","authors":"Riccardo Guanà, Ana Sofia Soto Torselli, Francesco De Leo, Benedetta Marino, Silvia Perin, Giada Morgani, Marco Ettore Allaix, Matilde Piglione, Valentina Di Martino, Enrico Costantino Falco, Fabrizio Gennari","doi":"10.1007/s00384-025-05017-2","DOIUrl":"10.1007/s00384-025-05017-2","url":null,"abstract":"<p><strong>Introduction: </strong>Colorectal carcinoma (CC) is a rare disease in the pediatric population, with an annual incidence of 1 in 10 million adolescents, and it accounts for approximately 1% of pediatric solid neoplasms. It is the most common primary gastrointestinal malignancy in children with the vast majority of CCs being adenocarcinoma (CA). Unfortunately, the proportion of poorly differentiated, mucinous type, signet-ring cell containing carcinomas is higher in younger patients than in adults. Moreover, due to the low awareness of the disease, diagnosis is usually delayed until advanced stages, resulting in an extremely poor prognosis. Surgery is the only curative modality for localized CAs, whereas adjuvant chemotherapy is the standard of care for patients with stage III cancer to eradicate micro-metastases.</p><p><strong>Patients and methods: </strong>In the last 10 years, we treated 3 patients diagnosed with CA: a 14-year-old female, a 15-year-old male, and a 15-year-old female. All patients presented to our Emergency Department with nonspecific symptoms of abdominal pain and vomiting.</p><p><strong>Results: </strong>All patients were subjected to laparoscopic tumor resection to relief intestinal obstruction. In the male patient, laparoscopy was converted to laparotomy to safely assess the anatomy because of strong peritoneal adhesions. No stomas were created, in order to improve quality of life. Oxaliplatin and 5-fluorouracil-based regimens were among the most commonly used chemotherapy combinations. The 15-year-old female and the 15-year-old male died 1 year after the surgical resection, while the 14-year-old female is still on follow-up.</p><p><strong>Conclusions: </strong>CAs behave aggressively in children; they not only show a poorer response to chemotherapy, but are also associated with extensive intramural spread and peritoneal carcinomatosis. Lack of awareness and timely intervention remain the main challenges for early diagnosis and improved prognosis of CA.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"40 1","pages":"237"},"PeriodicalIF":2.3,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12630307/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145549156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-19DOI: 10.1007/s00384-025-05035-0
Ang Shi, Jingwei Zheng, Dongze Wu, Xinxin Yang, Zhixuan Jiang, Xiaodong Chen, Weiteng Zhang, Weijian Sun, Ji Lin, Jun Cheng, Qiantong Dong, Xian Shen
Purpose: To compare perioperative outcomes and safety between the novel single-port robotic systems (SPRS) and the da Vinci Xi robotic system (DVRS) in radical colorectal cancer resection.
Methods: In this retrospective cohort study, 59 patients who underwent curative colorectal resection were assigned to either the SPRS group (n = 21) or the DVRS group (n = 38). Intraoperative metrics, postoperative recovery parameters, and complications were compared between groups.
Results: All procedures were successfully completed without open conversion and the number of lymph nodes harvested was comparable. The SPRS group demonstrated significantly longer operative times (298.86 ± 76.08 min vs. 227.84 ± 70.20 min; p < 0.001). No significant differences were observed in estimated blood loss, time of gastrointestinal recovery(first flatus), time of dietary resumption (liquid/soft diet), or 30-day readmission rates (p > 0.05). The DVRS group exhibited prolonged median postoperative hospitalization (10.00 days [IQR 8.00-11.75] vs. 8.00 days [IQR 7.00-9.00]; p < 0.05). Patients in the SPRS group reported significantly higher satisfaction scores regarding the cosmetic appearance of postoperative scars compared to those in the DVRS group(7.71 ± 1.01 vs. 6.66 ± 0.91; p < 0.001). Complication rates showed no statistical difference (p > 0.05). All complications were Clavien-Dindo grade I-II managed conservatively, except one SPRS case requiring endoscopic intervention for grade IIIa gastrointestinal hemorrhage.
Conclusions: The novel single-port robotic systems are safe and feasible for radical colorectal cancer surgery. They achieve short-term outcomes comparable to the da Vinci Xi system, with the advantages of a shorter hospitalization and better cosmetic outcomes but at the expense of a longer operative time.
目的:比较新型单孔机器人系统(SPRS)和达芬奇Xi机器人系统(DVRS)在大肠癌根治性切除术中的围手术期疗效和安全性。方法:在这项回顾性队列研究中,59例接受根治性结直肠切除术的患者被分为SPRS组(n = 21)和DVRS组(n = 38)。比较两组间术中指标、术后恢复参数及并发症。结果:所有手术均成功完成,无开放性转化,淋巴结数量相当。SPRS组手术时间明显延长(298.86±76.08 min vs 227.84±70.20 min; p < 0.05)。DVRS组术后中位住院时间延长(10.00天[IQR 8.00-11.75] vs. 8.00天[IQR 7.00-9.00]; p 0.05)。所有并发症均保守处理Clavien-Dindo I-II级,除了一例SPRS病例需要内镜介入治疗IIIa级胃肠道出血。结论:新型单孔机器人系统在大肠癌根治性手术中是安全可行的。它们的短期效果与达芬奇Xi系统相当,其优点是住院时间更短,美容效果更好,但代价是手术时间更长。
{"title":"Safety and feasibility of novel single-port robotic systems in colorectal cancer surgery: a comparative study with the da Vinci Xi system.","authors":"Ang Shi, Jingwei Zheng, Dongze Wu, Xinxin Yang, Zhixuan Jiang, Xiaodong Chen, Weiteng Zhang, Weijian Sun, Ji Lin, Jun Cheng, Qiantong Dong, Xian Shen","doi":"10.1007/s00384-025-05035-0","DOIUrl":"10.1007/s00384-025-05035-0","url":null,"abstract":"<p><strong>Purpose: </strong>To compare perioperative outcomes and safety between the novel single-port robotic systems (SPRS) and the da Vinci Xi robotic system (DVRS) in radical colorectal cancer resection.</p><p><strong>Methods: </strong>In this retrospective cohort study, 59 patients who underwent curative colorectal resection were assigned to either the SPRS group (n = 21) or the DVRS group (n = 38). Intraoperative metrics, postoperative recovery parameters, and complications were compared between groups.</p><p><strong>Results: </strong>All procedures were successfully completed without open conversion and the number of lymph nodes harvested was comparable. The SPRS group demonstrated significantly longer operative times (298.86 ± 76.08 min vs. 227.84 ± 70.20 min; p < 0.001). No significant differences were observed in estimated blood loss, time of gastrointestinal recovery(first flatus), time of dietary resumption (liquid/soft diet), or 30-day readmission rates (p > 0.05). The DVRS group exhibited prolonged median postoperative hospitalization (10.00 days [IQR 8.00-11.75] vs. 8.00 days [IQR 7.00-9.00]; p < 0.05). Patients in the SPRS group reported significantly higher satisfaction scores regarding the cosmetic appearance of postoperative scars compared to those in the DVRS group(7.71 ± 1.01 vs. 6.66 ± 0.91; p < 0.001). Complication rates showed no statistical difference (p > 0.05). All complications were Clavien-Dindo grade I-II managed conservatively, except one SPRS case requiring endoscopic intervention for grade IIIa gastrointestinal hemorrhage.</p><p><strong>Conclusions: </strong>The novel single-port robotic systems are safe and feasible for radical colorectal cancer surgery. They achieve short-term outcomes comparable to the da Vinci Xi system, with the advantages of a shorter hospitalization and better cosmetic outcomes but at the expense of a longer operative time.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"40 1","pages":"236"},"PeriodicalIF":2.3,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12627135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145549176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-18DOI: 10.1007/s00384-025-05030-5
Bruna Los, Bruno Aragão Rocha, Daniel Noce da Silva, Vinicius Moura Ribeiro, Marco Aurelio Kohara, Rodrigo Azevedo Rodrigues, Maria Carolina Tostes Pintão, Otavio Jose Eulalio Pereira, João Vicente de Morais Malvezzi, Flavia Helena da Silva, Pedro Henrique Araújo de Souza, Daniella Castro Araújo
Purpose: Early colorectal cancer (CRC) detection is crucial for effective treatment; however, traditional screening methods face challenges. Colonoscopy, though highly effective, has limited availability, and fecal immunochemical tests (FIT) are more accessible and cost-effective but suffer from low adherence. Our retrospective study aimed to develop a transparent artificial-intelligence model leveraging routine CBC data as a cost-effective method for CRC detection.
Methods: We conducted a retrospective analysis of 28,450 individuals aged 45-75 who underwent colonoscopy within six months of a complete blood count (CBC) test. Among them, 439 (1.8%) had CRC, 2,955 (11.8%) had advanced adenomas, and 21,662 (86.5%) had benign findings on colonoscopy. The database was divided into training (70%) and testing (30%) sets. The model was developed using ridge regression.
Results: Descriptive analysis revealed significant differences between CRC cases and controls across most CBC markers, CBC-derived ratios, and age (P < 0.001), except for lymphocytes. The model, based on red cell distribution width (RDW), systemic inflammation response index (SIRI), hemoglobin, and age, achieved an AUC of 0.77 (95% CI: 0.75-0.77) for CRC, comparable to a deep learning model (TabPFN). Interpretability analysis revealed that older age, elevated RDW and SIRI, and low hemoglobin were associated with CRC. In a subgroup (7.25%) with FIT results, FIT showed higher sensitivity for CRC (88%) than the model (64%), but lower specificity (77% vs. 81%).
Conclusion: Given CBC's widespread use and accessibility, this approach may be a scalable pre-screening tool to improve CRC risk stratification and optimize resource allocation, demonstrating how explainable AI may augment existing CRC screening programs.
{"title":"AI-driven pre-screening for colorectal cancer using complete blood counts: toward broader population impact.","authors":"Bruna Los, Bruno Aragão Rocha, Daniel Noce da Silva, Vinicius Moura Ribeiro, Marco Aurelio Kohara, Rodrigo Azevedo Rodrigues, Maria Carolina Tostes Pintão, Otavio Jose Eulalio Pereira, João Vicente de Morais Malvezzi, Flavia Helena da Silva, Pedro Henrique Araújo de Souza, Daniella Castro Araújo","doi":"10.1007/s00384-025-05030-5","DOIUrl":"10.1007/s00384-025-05030-5","url":null,"abstract":"<p><strong>Purpose: </strong>Early colorectal cancer (CRC) detection is crucial for effective treatment; however, traditional screening methods face challenges. Colonoscopy, though highly effective, has limited availability, and fecal immunochemical tests (FIT) are more accessible and cost-effective but suffer from low adherence. Our retrospective study aimed to develop a transparent artificial-intelligence model leveraging routine CBC data as a cost-effective method for CRC detection.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of 28,450 individuals aged 45-75 who underwent colonoscopy within six months of a complete blood count (CBC) test. Among them, 439 (1.8%) had CRC, 2,955 (11.8%) had advanced adenomas, and 21,662 (86.5%) had benign findings on colonoscopy. The database was divided into training (70%) and testing (30%) sets. The model was developed using ridge regression.</p><p><strong>Results: </strong>Descriptive analysis revealed significant differences between CRC cases and controls across most CBC markers, CBC-derived ratios, and age (P < 0.001), except for lymphocytes. The model, based on red cell distribution width (RDW), systemic inflammation response index (SIRI), hemoglobin, and age, achieved an AUC of 0.77 (95% CI: 0.75-0.77) for CRC, comparable to a deep learning model (TabPFN). Interpretability analysis revealed that older age, elevated RDW and SIRI, and low hemoglobin were associated with CRC. In a subgroup (7.25%) with FIT results, FIT showed higher sensitivity for CRC (88%) than the model (64%), but lower specificity (77% vs. 81%).</p><p><strong>Conclusion: </strong>Given CBC's widespread use and accessibility, this approach may be a scalable pre-screening tool to improve CRC risk stratification and optimize resource allocation, demonstrating how explainable AI may augment existing CRC screening programs.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"40 1","pages":"235"},"PeriodicalIF":2.3,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12627115/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145540605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: Antibiotic therapy may be an alternative in the treatment of uncomplicated appendicitis. The primary concern about antibiotic therapy is the need for appendectomy due to recurrent acute appendicitis after treatment. The optimal antibiotic choice, route of administration, and duration of treatment remain controversial. We aimed to demonstrate the long-term success of oral antibiotic therapy in uncomplicated appendicitis.
Methods: This was a single-center retrospective study including all patients diagnosed with uncomplicated acute appendicitis between January 2020 and December 2022, who were discharged from the emergency department on oral antibiotics without hospitalization. Treatment success was defined as the absence of appendectomy during follow-up. We reported long-term treatment success rates of oral antibiotic therapy. In addition, factors that may affect treatment success were evaluated.
Results: A total of 99 patients were included in the study. At 1 year, the treatment success rate was 76% (95% CI = 66-83%). At a median follow-up of 34 months, 70% (95% CI = 60-78%) remained free of surgery. The Kaplan-Meier analysis revealed that 80% of appendectomies due to recurrent acute appendicitis occurred within the first 10 months. There were no significant differences between patients who required appendectomy and those who did not regarding age, sex, WBC count, neutrophil-to-lymphocyte ratio, appendix diameter, or previous intravenous antibiotic use.
Conclusion: With a median follow-up of 34 months, oral antibiotic-only treatment prevented appendectomy in 70% of patients. Larger, prospective randomized studies are needed to identify factors influencing treatment success.
目的:抗生素治疗可能是治疗无并发症阑尾炎的另一种选择。对抗生素治疗的主要关注是由于治疗后复发的急性阑尾炎需要阑尾切除术。最佳的抗生素选择、给药途径和治疗时间仍然存在争议。我们的目的是证明口服抗生素治疗无并发症阑尾炎的长期成功。方法:这是一项单中心回顾性研究,纳入了2020年1月至2022年12月期间诊断为无并发症的急性阑尾炎的所有患者,这些患者在急诊出院时使用口服抗生素,未住院。治疗成功的定义为随访期间没有阑尾切除术。我们报告了口服抗生素治疗的长期治疗成功率。此外,还对可能影响治疗成功的因素进行了评估。结果:共纳入99例患者。1年时,治疗成功率为76% (95% CI = 66-83%)。在中位随访34个月时,70% (95% CI = 60-78%)患者仍然没有手术。Kaplan-Meier分析显示,80%因复发性急性阑尾炎而行阑尾切除术发生在前10个月内。需要阑尾切除术的患者与不需要阑尾切除术的患者在年龄、性别、白细胞计数、中性粒细胞与淋巴细胞比值、阑尾直径或既往静脉使用抗生素方面没有显著差异。结论:中位随访时间为34个月,仅口服抗生素治疗可预防70%的患者阑尾切除术。需要更大规模的前瞻性随机研究来确定影响治疗成功的因素。
{"title":"Oral antibiotic therapy without hospitalization in uncomplicated acute appendicitis: long-term results from a retrospective cohort study.","authors":"Alisina Bulut, Muhammed İkbal Akın, Vildan Görgülü, Fatma Nazlı Zorlu, Şakir Karpuz, Mümin Coşkun, Cumhur Yeğen","doi":"10.1007/s00384-025-05037-y","DOIUrl":"10.1007/s00384-025-05037-y","url":null,"abstract":"<p><strong>Purpose: </strong>Antibiotic therapy may be an alternative in the treatment of uncomplicated appendicitis. The primary concern about antibiotic therapy is the need for appendectomy due to recurrent acute appendicitis after treatment. The optimal antibiotic choice, route of administration, and duration of treatment remain controversial. We aimed to demonstrate the long-term success of oral antibiotic therapy in uncomplicated appendicitis.</p><p><strong>Methods: </strong>This was a single-center retrospective study including all patients diagnosed with uncomplicated acute appendicitis between January 2020 and December 2022, who were discharged from the emergency department on oral antibiotics without hospitalization. Treatment success was defined as the absence of appendectomy during follow-up. We reported long-term treatment success rates of oral antibiotic therapy. In addition, factors that may affect treatment success were evaluated.</p><p><strong>Results: </strong>A total of 99 patients were included in the study. At 1 year, the treatment success rate was 76% (95% CI = 66-83%). At a median follow-up of 34 months, 70% (95% CI = 60-78%) remained free of surgery. The Kaplan-Meier analysis revealed that 80% of appendectomies due to recurrent acute appendicitis occurred within the first 10 months. There were no significant differences between patients who required appendectomy and those who did not regarding age, sex, WBC count, neutrophil-to-lymphocyte ratio, appendix diameter, or previous intravenous antibiotic use.</p><p><strong>Conclusion: </strong>With a median follow-up of 34 months, oral antibiotic-only treatment prevented appendectomy in 70% of patients. Larger, prospective randomized studies are needed to identify factors influencing treatment success.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"40 1","pages":"234"},"PeriodicalIF":2.3,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12628372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145540571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-17DOI: 10.1007/s00384-025-04967-x
Cigdem Elif Celik, Elvin Chalabiyev, Volkan Gurler, Mehmet Ruhi Onur, Taha Koray Şahin, Omer Dizdar, Fusun Ozmen
Purpose: The study aims to evaluate the correlation between visceral adiposity, fatty liver, and survival in patients with metastatic colorectal cancer (mCRC).
Methods: The study included 131 adult patients with treatment-naive mCRC. The visceral and liver fat content was measured using baseline computed tomography (CT) images. The analysis used the 50th percentile (131.80 HU) visceral adiposity value as a cutoff. The visceral and liver fat content association with patient characteristics and outcomes was assessed.
Results: In the overall cohort, neither visceral adiposity (median OS 37.8 vs 36.7 months, HR = 0.83; p = 0.428) nor liver steatosis (median OS 46.0 vs 33.9 months, HR = 0.81; p = 0.370) showed significant association with OS. However, in patients with BMI ≥ 25 kg/m2, liver steatosis was associated with significantly shorter survival (median OS 35.2 vs 59.5 months; adjusted HR = 0.49; p = 0.040). Visceral adiposity remained non-significant across BMI subgroups.
Conclusion: We observed a possible association between liver steatosis and OS in patients with mCRC in the high BMI subgroup. Prospective studies are essential to validate these findings and the role of liver steatosis in the prognostic assessment of mCRC patients.
目的:本研究旨在评估转移性结直肠癌(mCRC)患者内脏脂肪、脂肪肝和生存之间的相关性。方法:该研究纳入了131例未接受治疗的成年mCRC患者。使用基线计算机断层扫描(CT)图像测量内脏和肝脏脂肪含量。分析使用第50百分位(131.80 HU)的内脏脂肪值作为临界值。评估了内脏和肝脏脂肪含量与患者特征和预后的关系。结果:在整个队列中,内脏脂肪(中位生存期37.8 vs 36.7个月,HR = 0.83; p = 0.428)和肝脏脂肪变性(中位生存期46.0 vs 33.9个月,HR = 0.81; p = 0.370)均未显示出与OS的显著关联。然而,在BMI≥25 kg/m2的患者中,肝脂肪变性与较短的生存期相关(中位生存期35.2 vs 59.5个月;调整后HR = 0.49; p = 0.040)。内脏脂肪在BMI亚组中仍然不显著。结论:我们观察到高BMI亚组mCRC患者的肝脏脂肪变性和OS之间可能存在关联。前瞻性研究对于验证这些发现和肝脂肪变性在mCRC患者预后评估中的作用至关重要。
{"title":"Assessment of the correlation between visceral adiposity and liver fat in metastatic colorectal cancer patients.","authors":"Cigdem Elif Celik, Elvin Chalabiyev, Volkan Gurler, Mehmet Ruhi Onur, Taha Koray Şahin, Omer Dizdar, Fusun Ozmen","doi":"10.1007/s00384-025-04967-x","DOIUrl":"10.1007/s00384-025-04967-x","url":null,"abstract":"<p><strong>Purpose: </strong>The study aims to evaluate the correlation between visceral adiposity, fatty liver, and survival in patients with metastatic colorectal cancer (mCRC).</p><p><strong>Methods: </strong>The study included 131 adult patients with treatment-naive mCRC. The visceral and liver fat content was measured using baseline computed tomography (CT) images. The analysis used the 50th percentile (131.80 HU) visceral adiposity value as a cutoff. The visceral and liver fat content association with patient characteristics and outcomes was assessed.</p><p><strong>Results: </strong>In the overall cohort, neither visceral adiposity (median OS 37.8 vs 36.7 months, HR = 0.83; p = 0.428) nor liver steatosis (median OS 46.0 vs 33.9 months, HR = 0.81; p = 0.370) showed significant association with OS. However, in patients with BMI ≥ 25 kg/m<sup>2</sup>, liver steatosis was associated with significantly shorter survival (median OS 35.2 vs 59.5 months; adjusted HR = 0.49; p = 0.040). Visceral adiposity remained non-significant across BMI subgroups.</p><p><strong>Conclusion: </strong>We observed a possible association between liver steatosis and OS in patients with mCRC in the high BMI subgroup. Prospective studies are essential to validate these findings and the role of liver steatosis in the prognostic assessment of mCRC patients.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"40 1","pages":"232"},"PeriodicalIF":2.3,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12620313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145534603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-17DOI: 10.1007/s00384-025-05031-4
Hao Zhang, Songtao Yu, Jun Xiang, Federico Maria Mongardini, Ludovico Docimo, Zekai Huang, Gang Wang, Yuliuming Wang, Yunxiao Liu, Chunlin Wang, Weiyuan Zhang, Yuping Zhu, Guiyu Wang, Meng Wang
Purpose: Current diagnostic modalities lack sufficient sensitivity for detecting omental metastasis (OM), often underestimating metastatic burden. Unlike traditional statistical model, machine learning (ML) model is designed to detect subtle variable interactions and model nonlinear patterns that traditional statistics overlook, enhancing the reliability of OM risk evaluation in clinical practice. The aim of the study was to build a ML model in preoperatively predicting OM in right-sided colon cancer (RCC) patients using a multicenter dataset.
Methods: This retrospective multicenter study included 1798 RCC patients: 1206 from Zhejiang Cancer Hospital (training set n = 804, test set n = 402) and 592 from the Second Affiliated Hospital of Harbin Medical University (validation set). OM status, tumor location, preoperative CEA level, preoperative CA199 level, Grade, histology, tumor size and age of patients were recorded. Six ML models including extreme gradient boosting (XGB), artificial neural network (ANN), logistic regression (LR), random forest (RF), support vector machine (SVM) and decision tree (DT) were developed for the OM prediction in RCC. The area under the receiver operator characteristic (ROC) curve (AUC), accuracy, sensitivity, specificity, precision, F1 score and decision curve analysis (DCA) were analyzed for judging predictive performance.
Results: The OM rates in training set, test set and validation set were 10.4%, 9.5% and 10.0%, respectively. The XGB model outperforming five other algorithms (ANN, RF, LR, SVM, and DT) across training set (AUC = 0.924, 0.096 gain vs LR), internal test (AUC = 0.868, 0.038 gain vs LR) and validation set (AUC = 0.766, 0.065 gain vs LR). The comparison of accuracy, sensitivity, specificity, precision and F1 score revealed the XGB model exhibited the best performance. The DCA curve also suggested that XGB had better clinical decision-making capability than the other five models. Feature importance analysis highlighted preoperative CEA level and tumor location as key predictors.
Conclusion: Our study developed and validated an XGB-based machine learning model that could accurately predict OM in RCC patients using routine preoperative variables. This model demonstrates strong discriminative ability and clinical utility, assisting personalized risk stratification and appropriate treatment decisions.
目的:目前的诊断方式在检测大网膜转移(OM)方面缺乏足够的敏感性,往往低估了转移负担。与传统的统计模型不同,机器学习(ML)模型旨在检测传统统计忽略的微妙变量相互作用并建模非线性模式,从而提高临床实践中OM风险评估的可靠性。该研究的目的是利用多中心数据集建立一个预测右侧结肠癌(RCC)患者术前OM的ML模型。方法:本回顾性多中心研究纳入1798例RCC患者,其中1206例来自浙江肿瘤医院(训练集n = 804,检验集n = 402), 592例来自哈尔滨医科大学第二附属医院(验证集n = 402)。记录OM状态、肿瘤位置、术前CEA水平、术前CA199水平、分级、组织学、肿瘤大小、患者年龄。建立了极端梯度增强(XGB)、人工神经网络(ANN)、逻辑回归(LR)、随机森林(RF)、支持向量机(SVM)和决策树(DT)等6种ML模型用于RCC的OM预测。分析受试者操作特征(ROC)曲线下面积(AUC)、准确度、灵敏度、特异性、精密度、F1评分和决策曲线分析(DCA)来判断预测效果。结果:训练集、测试集和验证集的OM率分别为10.4%、9.5%和10.0%。XGB模型在训练集(AUC = 0.924,增益0.096 vs LR)、内部测试(AUC = 0.868,增益0.038 vs LR)和验证集(AUC = 0.766,增益0.065 vs LR)上优于其他五种算法(ANN、RF、LR、SVM和DT)。准确度、灵敏度、特异度、精密度及F1评分比较显示,XGB模型表现最佳。DCA曲线也提示XGB比其他5种模型具有更好的临床决策能力。特征重要性分析强调术前CEA水平和肿瘤位置是关键的预测因素。结论:我们的研究开发并验证了基于xgb的机器学习模型,该模型可以使用常规术前变量准确预测RCC患者的OM。该模型具有较强的判别能力和临床应用价值,有助于进行个性化的风险分层和适当的治疗决策。
{"title":"Machine learning-based prediction model for omental metastasis in right-sided colon cancer patients: a retrospective multicenter study.","authors":"Hao Zhang, Songtao Yu, Jun Xiang, Federico Maria Mongardini, Ludovico Docimo, Zekai Huang, Gang Wang, Yuliuming Wang, Yunxiao Liu, Chunlin Wang, Weiyuan Zhang, Yuping Zhu, Guiyu Wang, Meng Wang","doi":"10.1007/s00384-025-05031-4","DOIUrl":"10.1007/s00384-025-05031-4","url":null,"abstract":"<p><strong>Purpose: </strong>Current diagnostic modalities lack sufficient sensitivity for detecting omental metastasis (OM), often underestimating metastatic burden. Unlike traditional statistical model, machine learning (ML) model is designed to detect subtle variable interactions and model nonlinear patterns that traditional statistics overlook, enhancing the reliability of OM risk evaluation in clinical practice. The aim of the study was to build a ML model in preoperatively predicting OM in right-sided colon cancer (RCC) patients using a multicenter dataset.</p><p><strong>Methods: </strong>This retrospective multicenter study included 1798 RCC patients: 1206 from Zhejiang Cancer Hospital (training set n = 804, test set n = 402) and 592 from the Second Affiliated Hospital of Harbin Medical University (validation set). OM status, tumor location, preoperative CEA level, preoperative CA199 level, Grade, histology, tumor size and age of patients were recorded. Six ML models including extreme gradient boosting (XGB), artificial neural network (ANN), logistic regression (LR), random forest (RF), support vector machine (SVM) and decision tree (DT) were developed for the OM prediction in RCC. The area under the receiver operator characteristic (ROC) curve (AUC), accuracy, sensitivity, specificity, precision, F1 score and decision curve analysis (DCA) were analyzed for judging predictive performance.</p><p><strong>Results: </strong>The OM rates in training set, test set and validation set were 10.4%, 9.5% and 10.0%, respectively. The XGB model outperforming five other algorithms (ANN, RF, LR, SVM, and DT) across training set (AUC = 0.924, 0.096 gain vs LR), internal test (AUC = 0.868, 0.038 gain vs LR) and validation set (AUC = 0.766, 0.065 gain vs LR). The comparison of accuracy, sensitivity, specificity, precision and F1 score revealed the XGB model exhibited the best performance. The DCA curve also suggested that XGB had better clinical decision-making capability than the other five models. Feature importance analysis highlighted preoperative CEA level and tumor location as key predictors.</p><p><strong>Conclusion: </strong>Our study developed and validated an XGB-based machine learning model that could accurately predict OM in RCC patients using routine preoperative variables. This model demonstrates strong discriminative ability and clinical utility, assisting personalized risk stratification and appropriate treatment decisions.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"40 1","pages":"233"},"PeriodicalIF":2.3,"publicationDate":"2025-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12620311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145534598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-13DOI: 10.1007/s00384-025-05011-8
Cihad Tatar, Tayfun Bisgin, Aras Emre Canda, Feza Karakayali, Ethem Gecim, Ali Cihat Yildirim, Erdinc Cetinkaya, Ibrahim Ethem Cakcak, Ibrahim H Ozata, Mehmet Ali Koc, Huseyin Onur Aydin, Osman Bozbiyik, Ramazan Kozan, Yusuf Sevim, Ilknur Erenler Bayraktar
Purpose: Treatment strategies for early and locally advanced rectal cancer are evolving, particularly with the increasing use of non-operative management and multidisciplinary decision-making. The aim of this study is to establish an expert-based consensus on the preferred treatment strategies for early and locally advanced rectal cancer.
Methods: A 12-member steering committee was established to conduct a modified Delphi consensus process on rectal cancer management. The committee performed a systematic literature review (2014-2024) to inform survey development. A 49-question survey, including open-ended and multiple-choice items, was developed and refined. A panel of 44 colorectal surgery experts was selected based on academic contributions, and two Delphi rounds were conducted anonymously. Consensus was defined as ≥ 70% agreement. Based on panel responses, 29 consensus statements were formulated.
Results: The panel reached consensus on the importance of multidisciplinary evaluation and surgical expertise in total mesorectal excision. Structured MRI reporting was recommended. Total neoadjuvant therapy was preferred for high-risk tumors. Non-operative management was recommended in cases of clinical complete response, with defined surveillance strategies. The role of biopsy in near-complete responders was also addressed.
Conclusions: This international consensus provides structured guidance on the management of rectal cancer, emphasizing multidisciplinary planning, the role of total neoadjuvant therapy in organ preservation, and rigorous surveillance protocols in non-operative management. These recommendations aim to standardize care and support evidence-informed clinical decision-making.
{"title":"International expert Delphi consensus on management of early and locally advanced rectal cancer.","authors":"Cihad Tatar, Tayfun Bisgin, Aras Emre Canda, Feza Karakayali, Ethem Gecim, Ali Cihat Yildirim, Erdinc Cetinkaya, Ibrahim Ethem Cakcak, Ibrahim H Ozata, Mehmet Ali Koc, Huseyin Onur Aydin, Osman Bozbiyik, Ramazan Kozan, Yusuf Sevim, Ilknur Erenler Bayraktar","doi":"10.1007/s00384-025-05011-8","DOIUrl":"10.1007/s00384-025-05011-8","url":null,"abstract":"<p><strong>Purpose: </strong>Treatment strategies for early and locally advanced rectal cancer are evolving, particularly with the increasing use of non-operative management and multidisciplinary decision-making. The aim of this study is to establish an expert-based consensus on the preferred treatment strategies for early and locally advanced rectal cancer.</p><p><strong>Methods: </strong>A 12-member steering committee was established to conduct a modified Delphi consensus process on rectal cancer management. The committee performed a systematic literature review (2014-2024) to inform survey development. A 49-question survey, including open-ended and multiple-choice items, was developed and refined. A panel of 44 colorectal surgery experts was selected based on academic contributions, and two Delphi rounds were conducted anonymously. Consensus was defined as ≥ 70% agreement. Based on panel responses, 29 consensus statements were formulated.</p><p><strong>Results: </strong>The panel reached consensus on the importance of multidisciplinary evaluation and surgical expertise in total mesorectal excision. Structured MRI reporting was recommended. Total neoadjuvant therapy was preferred for high-risk tumors. Non-operative management was recommended in cases of clinical complete response, with defined surveillance strategies. The role of biopsy in near-complete responders was also addressed.</p><p><strong>Conclusions: </strong>This international consensus provides structured guidance on the management of rectal cancer, emphasizing multidisciplinary planning, the role of total neoadjuvant therapy in organ preservation, and rigorous surveillance protocols in non-operative management. These recommendations aim to standardize care and support evidence-informed clinical decision-making.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"40 1","pages":"231"},"PeriodicalIF":2.3,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12615519/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145503677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}